A more recent version of this article appeared on May 11, 2001

This Article Abstract Full Text (PDF) Data Supplement All Versions of this Article: 88/9/888    most recent hh0901.090299v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lassègue, B. Articles by Griendling, K. K. Search for Related Content PubMed Articles by Lassègue, B. Articles by Griendling, K. K. Related Collections Cell signalling/signal transduction Gene regulation Growth factors/cytokines Oxidant stress

(Circulation Research. 2001;0:hh0901.090299.)
© 2001 American Heart Association, Inc.

Article

Novel gp91^phox Homologues in Vascular Smooth Muscle Cells

nox1 Mediates Angiotensin II–Induced Superoxide Formation and Redox-Sensitive Signaling Pathways

Bernard Lassègue, Dan Sorescu, Katalin Szöcs, QiQin Yin, Marjorie Akers, Yong Zhang, Sharon L. Grant, J. David Lambeth Kathy K. Griendling

From the Department of Medicine, Division of Cardiology (B.L., D.S., K.S., Q.Q.Y., M.A., Y.Z., S.L.G., K.K.G.) and Department of Biochemistry (J.D.L.), Emory University, Atlanta, Ga.

Correspondence to Bernard Lassègue, Emory University, Division of Cardiology, 1639 Pierce Dr, 319 WMB, Atlanta, GA 30322. E-mail medbpl{at}emory.edu

Abstract

Abstract—Emerging evidence indicates that reactive oxygen species are important regulators of vascular function. Although NAD(P)H oxidases have been implicated as major sources of superoxide in the vessel wall, the molecular identity of these proteins remains unclear. We recently cloned nox1 (formerly mox-1), a member of a new family of gp91^phox homologues, and showed that it is expressed in proliferating vascular smooth muscle cells (VSMCs). In this study, we examined the expression of three nox family members, nox1, nox4, and gp91^phox, in VSMCs, their regulation by angiotensin II (Ang II), and their role in redox-sensitive signaling. We found that both nox1 and nox4 are expressed to a much higher degree than gp91^phox in VSMCs. Although serum, platelet-derived growth factor (PDGF), and Ang II downregulated nox4, they markedly upregulated nox1, suggesting that this enzyme may account for the delayed phase of superoxide production in these cells. Furthermore, an adenovirus expressing antisense nox1 mRNA completely inhibited the early phase of superoxide production induced by Ang II or PDGF and significantly decreased activation of the redox-sensitive signaling molecules p38 mitogen-activated protein kinase and Akt by Ang II. In contrast, redox-independent pathways induced by PDGF or Ang II were unaffected. These data support a role for nox1 in redox signaling in VSMCs and provide insight into the molecular identity of the VSMC NAD(P)H oxidase and its potentially critical role in vascular disease.

Key Words: nox1 • nox4 • superoxide • angiotensin II • vascular smooth muscle

Reactive oxygen species (ROS) have recently been recognized as important signaling molecules in vascular cells.¹ The production of ROS, most notably superoxide (O₂^·-) and hydrogen peroxide (H₂O₂), by vascular smooth muscle cells (VSMCs) can be regulated by vasoactive hormones, including angiotensin II (Ang II),¹ thrombin,² and platelet-derived growth factor (PDGF).³ It has been proposed that ROS serve as signal transducers, participating in agonist-induced activation of such crucial protein kinases as p38 mitogen-activated protein kinase (MAPK) and Akt.^{4 5} Not only do these molecules function in a physiological manner, but they also mediate many of the cardinal features of atherosclerosis and hypertension, including endothelial dysfunction, abnormal VSMC growth, and inflammation.⁶ The proteins and enzymes that produce ROS or serve as the antioxidant defense system are thus important determinants of the course of vascular disease.

Several investigators identified an NAD(P)H oxidase activity as the major source of ROS in the vessel wall.^{7 8} This activity has been found in endothelial cells,⁹ VSMCs,¹⁰ and the adventitia¹¹ and contributes to the regulation of vascular tone and smooth muscle cell growth.^{8 12} Although the molecular identities of the proteins responsible for this activity are unknown, some insights have been gained using antisense technology or inactivating antibodies. The vascular NAD(P)H oxidases share some similarities with the multisubunit enzyme complex that comprises the neutrophil respiratory burst oxidase.¹³ Endothelial cells express the flavocytochrome b₅₅₈ subunits gp91^phox and p22^phox, as well as the cytosolic factors p47^phox and p67^phox and the small molecular weight G protein rac-1.^{14 15 16 17} All components of the neutrophil oxidase have also been found in adventitial cells,¹¹ but so far only p67^phox and rac-1 have been shown to be functionally important.^{18 19} In contrast, whereas VSMCs contain p22^phox20 and p47^phox,² expression of p67^phox and the catalytic moiety gp91^phox has been difficult to demonstrate.²¹ Transfection of VSMCs with antisense p22^phox markedly inhibits NADH- and NADPH-dependent O₂^·- production in response to Ang II and platelet-derived products,^{21 22 23} demonstrating that p22^phox does contribute to hormone-sensitive NAD(P)H oxidase activity.

The apparent lack of gp91^phox in VSMCs raises the question of what protein provides the electron transport function that participates in NAD(P)H oxidase activity. We recently cloned a gp91^phox homologue, nox1 (for NAD(P)H oxidase, formerly termed mitogenic oxidase-1 [mox-1]), from human colon and rat VSMCs that supports O₂^·- production and increases growth when transfected into NIH 3T3 fibroblasts.²⁴ In VSMCs, nox1 mediates serum-induced growth,²⁴ but very little is known about the regulation and function of this protein or that of newly identified nox family members, such as nox4.²⁵

In this study, we found that expression of nox1 and nox4 mRNAs greatly exceeds that of gp91^phox in rat VSMCs. Furthermore, nox1 and nox4 messages were oppositely regulated by agonists. Because nox1 was markedly upregulated by Ang II and PDGF, we assessed its role in O₂^·- production. Infection with nox1 antisense adenovirus inhibited Ang II–induced and PDGF-induced O₂^·- production and Ang II–stimulated redox-dependent signaling pathways. This study demonstrates for the first time that nox1 is involved in Ang II signaling and is thus potentially critical to vascular disease.

Materials and Methods

Cell Culture
VSMCs were isolated from rat aortas by enzymatic digestion as described previously.²⁶ Cells were grown in culture medium with 4.5 g/L glucose, supplemented with 10% calf serum, 2 mmol/L glutamine, 100 U/mL penicillin, and 100 µg/mL streptomycin, and passaged twice a week. Cells between passages 8 and 20 were used in experiments.

Northern Blots
Total RNA was separated by electrophoresis on formaldehyde gels, transferred, and crosslinked onto neutral nylon membranes. Blots were hybridized with radiolabeled rat nox1 probe and washed 2 to 3 times for 20 minutes in 1xSSC+0.1% SDS at 55°C. Signals measured with a PhosphorImager were normalized to 28S RNA detected with ethidium bromide.

Quantitative Polymerase Chain Reaction
VSMC cDNA was amplified using the LightCycler (Roche) real-time thermocycler. Message copy numbers were obtained from standard curves generated with genuine rat nox1, nox4, and gp91^phox templates.

Adenoviruses
The pAdTrack-CMV vector,²⁷ which contains the green fluorescent protein (GFP) gene, was used to prepare viruses with either no additional insert (AdGFP), hemagglutinin (HA)-tagged nox1 (Adnox1), or antisense nox1 (AdASnox1). VSMCs were transduced overnight in medium with 0.1% calf serum using a multiplicity of infection (MOI) of 5, washed, and incubated for 24 to 48 hours in the same medium without virus before additional incubations specified below.

Immunoblotting of HA-Tagged nox1
VSMCs transduced with one virus at 5 or 2.5 MOI each of two viruses were sonicated in lysis buffer with 1 mol/L sodium chloride and 200 mmol/L dithiothreitol. After separation by SDS-PAGE and transfer to nitrocellulose membranes, signals were detected with anti-HA antibody, visualized with enhanced chemiluminescence, and quantified by laser densitometry.

Superoxide Assays
Dihydroethidium (DHE), which is specifically oxidized to ethidium by O₂^·-, was used in a modification of the method of Miller et al.²⁸ Adenovirus-transduced VSMCs were incubated for an additional 12 hours in medium with 2% calf serum, harvested with trypsin, resuspended in colorless HBSS (10⁶ cells/mL), and filtered through a nylon mesh. Cells were incubated in the dark for 30 minutes at 37°C with 5 µmol/L DHE and agonist. Flow cytometry (FACScan, Becton Dickinson) was used to select a homogeneous population of 5000 live cells according to forward and side scatter. The geometric mean of ethidium fluorescence intensity (excitation 488 nm, emission 610 nm) in the population was used for analysis.

In some experiments, electron spin resonance with DEPMPO as a spin trap was used to measure NAD(P)H oxidase activity as described previously.²⁹

Immunoblotting of Akt, p38MAPK, and Extracellular Signal–Regulated Kinases 1 and 2
Adenovirus-transduced VSMCs were incubated for an additional 24 hours in medium with 0.1% calf serum and exposed to Ang II in serum-free medium at 37°C. After separation by SDS-PAGE and transfer to nitrocellulose membranes, total enzymes and their phosphorylated forms, an index of kinase activity, were detected using specific antibodies, visualized by enhanced chemiluminescence, and quantified by laser densitometry.

Statistical Analysis
Probability values were obtained by ANOVA followed by contrast analysis and considered significant below 0.05.

An expanded Materials and Methods section can be found in an online data supplement available at http://www.circresaha.org.

Results

Expression of nox Homologues in VSMCs
As a first step toward establishing the molecular identity of the VSMC oxidase responsible for agonist-induced O₂^·- production, we measured the relative expression of the nox family members gp91^phox, nox1, and nox4. We first cloned nox4 and a fragment of gp91 whose sequences had not been reported in the rat. A 1.6-kb fragment of gp91^phox was obtained from the rat lung macrophage cell line NR8383 using nested reverse transcriptase–polymerase chain reaction (RT-PCR) (GenBank AF298656). Sequencing revealed its similarity to the mouse sequence (96% identity in predicted amino acid sequence) and confirmed its identity. Using rat primers, we were then able to obtain a low-abundance RT-PCR product from rat VSMC RNA. This product was sequenced and found to be identical to rat macrophage gp91^phox, thus confirming its expression in VSMCs. Evidence of nox4 expression was obtained by RT-PCR amplification of an abundant 2.1-kb product from rat VSMC RNA. The sequence was completed by 5' rapid amplification of cDNA ends. A full-length 2.2-kb product was amplified, cloned, and sequenced (GenBank AY027527). Rat nox4-deduced amino acid sequence is 97% identical to mouse nox4 protein.

The relative expression of gp91^phox, nox1, and nox4 was assessed by quantitative PCR (primer sequences can be found in the online data supplement available at http://www.circresaha.org). As shown in the Table, in proliferating rat VSMCs, the numbers of RNA molecules of nox1 and nox4 were 3000-fold greater than gp91^phox, which was just above the detection limit in our assay. This low abundance explains the previous failure to detect gp91^phox mRNA by Northern blotting. This result suggests that nox1 and nox4, rather than gp91^phox, may participate in O₂^·- generation in VSMCs.

View this table: [in this window] [in a new window]   Table 1. mRNA Abundance in Proliferating VSMCs

Regulation of nox mRNA Expression by Ang II
Many proteins that mediate the cellular responses to Ang II are themselves regulated by this agonist, including the AT₁ receptor,³⁰ Gq,³¹ GRK-5,³² and RGS-2.³³ To gain insight into a possible involvement of nox1 and nox4 in signaling, we measured the regulation of their messages by Ang II. As shown in Figure 1, after 8 hours, Ang II upregulated nox1 message 4-fold and decreased nox4 mRNA by 40%. These effects were sustained for 4 to 12 hours, suggesting that nox1, rather than nox4, may be involved in the induction of O₂^·- production by Ang II observed during this time frame.¹⁰

View larger version (18K): [in this window] [in a new window]   Figure 1. Regulation of nox1 and nox4 messages by Ang II. Confluent VSMCs were exposed to 100 nmol/L Ang II for the indicated time. RNAs were assayed by real-time PCR. nox mRNA signals were normalized to 18S rRNA and expressed as percent control. Data represent the average±SEM of 2 to 4 independent experiments. Error bars not shown are within the height of the symbol.

Ang II upregulated nox1 message in a dose-dependent manner, with an EC₅₀ of 3 nmol/L and a maximal response at 1 µmol/L (Figure 2). These concentrations agree well with those previously reported for other AT₁ receptor-mediated responses.³⁴

View larger version (14K): [in this window] [in a new window]   Figure 2. Concentration-effect relationship of Ang II–induced nox1 upregulation. Confluent VSMCs were exposed to the indicated concentrations of Ang II for 4 hours. Total RNA was purified and assayed for nox1 message by Northern hybridization. Signals were normalized to 28S rRNA and expressed relative to the difference between the highest and lowest values in each experiment (% range). Data represent the average±SEM from 3 independent experiments.

Activation of protein kinase C (PKC) is one mechanism by which Ang II regulates gene expression in VSMCs. Importantly, the PKC activator 12,13-phorbol myristate acetate (PMA) (100 nmol/L) also upregulated nox1 mRNA in VSMCs (Figure 3). Preincubation with 10 µmol/L GF109203X, which efficiently inhibits PKC in VSMCs,³⁰ decreased basal nox1 message and completely prevented both Ang II–induced and PMA-induced upregulation of nox1 (Figure 3). These observations suggest that PKC activity is required for Ang II–induced nox1 upregulation.

View larger version (45K): [in this window] [in a new window]   Figure 3. PKC mediates Ang II–induced nox1 upregulation. Confluent VSMCs were preincubated for 20 minutes with or without the PKC inhibitor GF109203X (10 µmol/L) and exposed to 100 nmol/L Ang II or PMA for 6 hours. nox1 mRNA was assayed by Northern hybridization. Data represent the average±SEM mRNA signal normalized to 28S rRNA from 3 independent experiments and expressed as percent control. **P<0.01, ***P<0.001 compared with absence of inhibitor.

Regulation of nox mRNA Expression by Growth Factors
We have previously shown that nox1 is upregulated in response to PDGF.²⁴ Given the opposing effects of Ang II on nox1 and nox4 mRNA expression, we determined whether other growth-promoting agents also had differential effects on nox1 and nox4. VSMCs were made quiescent by exposure to culture medium with 0.1% calf serum for 3 days. Subsequent incubation with 10% calf serum for 4 hours upregulated nox1 message (179±8% of control) and decreased nox4 mRNA (32±7% of control). Similarly, stimulation for 12 hours with 20 ng/mL PDGF increased nox1 mRNA (481±39% of control) and downregulated nox4 message (13±1% of control). The induction of nox1 by PDGF was correlated with expression of active enzyme, as measured by electron spin resonance (3.3±1.1-fold increase in NAD(P)H oxidase activity after 16 hours).

These results confirm previous observations²⁴ and additionally suggest that nox1 rather than nox4 may be the oxidase involved in cell growth and proliferation. Therefore, we investigated the function of nox1 in Ang II and PDGF signaling. It has been previously shown that both Ang II–induced hypertrophy and PDGF-induced hyperplasia require rapid redox-sensitive, NAD(P)H oxidase–dependent activation of specific signaling molecules, including p38MAPK,⁴ extracellular signal–regulated kinase (ERK) 1 and ERK2,³ and Akt.⁵ Therefore, to study the role of nox1 in growth-related signaling, we chose to examine short-term responses that are known to be redox-sensitive to avoid the confounding effects of nox1 and nox4 message regulation by these agonists.

Adenovirus-Mediated Antisense nox1 Expression
We have previously shown that low-efficiency transfection of nox1 antisense in VSMCs partially inhibits O₂^·- production.²⁴ To obtain high-efficiency expression of full-length antisense nox1 mRNA, we now use a recombinant adenovirus (AdASnox1). Transduction of VSMCs with AdASnox1 led to expression of GFP in >90% of the cells 24 to 72 hours after infection (Figure 4A). Expression of antisense nox1 mRNA in infected cells was verified by RT-PCR (Figure 4B). To ensure that overexpression of antisense nox1 message effectively decreased nox1 protein and because an antibody against nox1 is not presently available, we coexpressed HA-tagged nox1 and antisense nox1 using appropriate adenovirus vectors. Figure 4C shows that overexpression of nox1 produced an intense band at the expected size as well as apparent smaller cleavage products. These bands were completely abolished by coexpression of AdASnox1, indicating that treatment with the antisense was effective.

View larger version (31K): [in this window] [in a new window]   Figure 4. Expression of antisense nox1 in rat VSMCs. A, Confocal microscopy images of GFP fluorescence at 540 nm. Subconfluent VSMCs were transduced with vector control (AdGFP) or antisense nox1 (AdASnox1) adenoviruses. Greater than 90% of the cells were positive for GFP fluorescence after 48 hours. These pictures are representative of 4 independent experiments. B, RT-PCR from virus-infected VSMC RNA. Antisense nox1 message was amplified using the vector-specific primer c+1 and the nox1-specific primers n1+3, n1+4, or n1+5. PCR products of the expected sizes (0.6, 0.9, and 1.1 kb) were obtained from AdASnox1 samples and were absent in AdGFP samples. Data are representative of 2 independent experiments. C, Western blot of overexpressed HA-tagged nox1. VSMCs were transduced with the indicated viruses, either 5 MOI of a single virus or 2.5 MOI each of two viruses. Overexpression of nox1 (Adnox1), produced two prominent bands (arrows, the upper band is 65 kDa) absent in the control (AdGFP), which disappeared on coexpression of antisense nox1 (AdASnox1) (rightmost lane). Blot is representative of 2 independent experiments.

Suppression of Agonist-Stimulated O₂^·- Production by nox1 Antisense
We next assessed the role of nox1 in agonist-induced O₂^·- production. Adenovirus-transduced VSMCs were assayed for O₂^·- using flow cytometry and DHE.^{28 35} Figure 5 shows that stimulation of VSMCs for 30 minutes with either 100 nmol/L Ang II or 20 ng/mL PDGF increased O₂^·- generation in cells transduced with the control adenovirus AdGFP, as expected.^{3 10} In contrast, the effect of both agonists was abolished in cells in which nox1 levels were decreased by transduction with AdASnox1, indicating that nox1 is required for stimulation of O₂^·- production by Ang II and PDGF. This result is consistent with our previous observation that antisense nox1 inhibited O₂^·- production in VSMC membranes.²⁴ The increased baseline O₂^·- in AdASnox1-infected cells suggests that another source of O₂^·- may be upregulated to compensate for the absence of nox1.

View larger version (42K): [in this window] [in a new window]   Figure 5. Effect of antisense nox1 expression on Ang II–induced and PDGF-induced superoxide formation. Virus-infected VSMCs were exposed for 30 minutes to the O2·--specific dye DHE (5 µmol/L) with 100 nmol/L Ang II or 20 ng/mL PDGF. Ethidium fluorescence was measured by flow cytometry. Data are expressed as percent control in AdGFP-transduced cells and represent the average±SEM of 3 independent experiments. *P<0.05 compared with the same treatment in AdGFP-transduced cells.

Effect of Antisense nox1 on Redox-Sensitive Signaling Pathways
The function of ROS as signaling molecules depends on the regulation of their production and metabolism as well as on their subcellular localization. To determine whether nox1-derived ROS are capable of regulating signal transduction in response to Ang II and PDGF, we examined the effect of nox1 antisense expression on activation of two redox-sensitive signaling pathways, p38MAPK and Akt,^{4 5} as well as the redox-independent ERK1/2 pathway.⁴ Figures 6A and 6B show that in AdGFP (vector control)-transduced VSMCs, Ang II phosphorylated Akt, p38MAPK, and ERK1/2, as expected.^{4 5} In contrast, after transduction with AdASnox1, phosphorylation of Akt and p38MAPK was significantly inhibited (45% and 47% inhibition at 10 minutes, respectively), whereas ERK1/2 was unaffected.

View larger version (46K): [in this window] [in a new window]   Figure 6. Effect of antisense nox1 on redox-sensitive signaling pathways. Virus-infected VSMCs were exposed to Ang II or PDGF for the indicated times. The phosphorylated forms of Akt, p38MAPK, and ERK1/2 were assayed by immunoblotting using specific primary antibodies. A, Representative Western blots obtained after stimulation with 100 nmol/L Ang II. B, Densitometric analysis of experiments performed as in panel A. Data represent the average±SEM of independent triplicate (Akt, p38MAPK) and duplicate (ERK1/2) experiments. *P<0.05, **P<0.01 compared with AdGFP-infected cells. C, Western blot of phospho-ERK1/2 obtained after stimulation with 20 ng/mL PDGF. This picture is representative of 3 independent experiments.

In contrast to the results of Sundarasen et al,³ in our system, phosphorylation of ERK1/2 by PDGF is redox-independent, because it was not inhibited by a 1-hour preincubation with 10 mmol/L N-acetyl cysteine (result not shown). Consistent with this observation, phosphorylation of ERK1/2 by PDGF was unaffected by AdASnox1 (Figure 6C), as would be expected in the case of redox-independent events.

These results indicate that nox1 antisense does not interfere with activation of Ang II or PDGF receptors but that it specifically inhibits redox-dependent signaling pathways. This observation supports the validity of the antisense method and confirms the importance of ROS in Ang II signaling. Furthermore, nox1 seems to be involved in O₂^·- production by both agonists and in at least two kinase-mediated Ang II signaling events in VSMCs.

Discussion

The origins of ROS in the vessel wall are of intense interest, because accumulating evidence indicates that these molecules participate in the pathogenesis of vascular disease.⁶ It has become clear that NAD(P)H oxidases are a major source of O₂^·- in vascular cells.^{7 8 10 36} Studies into the molecular composition of these proteins have proceeded on the assumption that the vascular enzymes are structurally similar to the 5-subunit neutrophil oxidase, but the apparent absence in VSMCs of gp91^phox, the major electron transport subunit of the enzyme, has cast doubt on this presumption. The recent discovery of the gp91^phox homologue nox1, which is expressed in proliferating VSMCs,²⁴ and other nox family members²⁵ provides a possible explanation to this paradox. We now demonstrate that both nox1 and nox4 are expressed in VSMCs and that nox1 is involved in the response of VSMCs to the major pro-oxidant agonist Ang II.

Within the last year, five new homologues of gp91^phox were identified and a nomenclature for this protein family was proposed.²⁵ Unlike gp91^phox, these new proteins are not expressed in phagocytes and their biochemical activities are not limited to that of an NADPH oxidase.²⁵ Their physiological functions still require detailed characterization. nox1, cloned from human colon and rat aortic VSMCs,²⁴ participates in O₂^·- production and cell proliferation. An alternatively spliced shorter form of nox1 primarily serves as a H⁺ channel.³⁷ The function of the nox3 homologue^{25 38} is still unknown but may be related to development, because it is expressed in fetal kidney.³⁸ The nox4 homologue,²⁵ prominently expressed in adult kidney, may serve as an oxygen sensor in the regulation of erythropoietin synthesis.³⁹ Two additional homologues of gp91^phox, duox1 and duox2,²⁵ which have an amino-terminal peroxidase domain, are likely involved in thyroid hormone synthesis.^{40 41} The present study indicates that nox1 and nox4 mRNAs are much more abundant than gp91^phox in VSMCs. The messages for the other oxidases listed above are barely, if at all, detectable in VSMCs by RT-PCR (B.L., K.K.G., unpublished data, 2000). Future studies will be required to determine which members of this expanding family of gp91^phox homologues are important in specific aspects of vascular disease.

Expression of nox1 and nox4 mRNAs clearly predominates over that of gp91^phox in VSMCs (Table). Although we found that rat aortic VSMCs do express gp91^phox mRNA, its level is almost undetectable to the point where it may be expressed in only a subset of cells. The need for more than one NAD(P)H oxidase catalytic subunit is somewhat paradoxical, especially because nox1 and nox4 are oppositely regulated (Figure 1). The most parsimonious explanation of these observations is that the location of O₂^·- production is important, as expected when dealing with a signaling molecule (O₂^·-) with an extremely short half-life and diffusion distance. In fact, using the PSORT program (available at http://psort.nibb.ac.jp [Proteome, Inc]) to predict protein localization, we find that while nox1 is most likely present both in plasma membrane and endoplasmic reticulum, nox4 is predicted to be in endoplasmic reticulum only. Although the actual intracellular location of these enzymes is presently unknown, our results indicate that nox1 is coupled to growth factor signaling. It is clearly required for short-term Ang II–induced O₂^·- generation (Figure 5). The parallel upregulation of nox1 message and enzyme activity additionally suggests that although existing nox1 can be rapidly activated by Ang II, its expression may be limiting for long-term NAD(P)H oxidase activity. Similarly, upregulation of nox1 message within hours of exposure to PMA (Figure 3) is consistent with the prolonged stimulation of vascular oxidase activity by this compound (B.L., D.S., K.K.G., unpublished observations, 2000). This raises the possibility that other hypertrophic and hyperplastic agents that activate PKC may also upregulate nox1. This prediction is supported by the fact that nox1 is upregulated by the growth-promoting agent PDGF. In contrast, the downregulation of nox4 observed after exposure to Ang II, serum, or PDGF suggests that this enzyme serves another purpose in VSMCs. In fact, nox4 levels are dramatically increased by serum deprivation (K.S., Q.Y., B.L., K.K.G., unpublished observations, 2001), raising the possibility that nox4 is involved in maintaining the quiescent phenotype.

Because nox1 is preferentially expressed in proliferating cells rather than in quiescent tissue²⁴ and is upregulated by growth factors such as PDGF and Ang II, it seems likely that nox1 functions as a growth-promoting protein in VSMCs. We have previously reported that nox1 antisense inhibits serum-induced mitogenesis,²⁴ and our present data indicate that nox1 specifically mediates activation of the redox-sensitive signaling molecules p38MAPK and Akt, both of which are required for VSMC hypertrophy.^{4 5} Thus, nox1 is likely to be upregulated in vasculopathies that are characterized by proliferation or hypertrophy of smooth muscle, including restenosis after angioplasty, atherosclerosis, and hypertension. Of interest, ROS have been proposed to play a causal role in each of these processes.⁶

Adenovirus-mediated overexpression of antisense mRNA was used as a means to establish the function of nox1 in VSMCs. Antisense mRNA is thought to impair various stages of mRNA metabolism, such as transcription, processing, and translation. Formation of sense and antisense duplex RNA may lead to impaired translation without downregulation of the native message. To assess the effectiveness of treatment with antisense nox1, we verified the high transfection efficiency provided by the adenovirus (Figure 4A) and expression of antisense message (Figure 4B). In addition, treatment with antisense nox1 completely blocked overexpression of epitope-tagged nox1 protein (Figure 4C) and thus presumably also downregulated native nox1. Because an antibody against nox1 is not yet available, direct measurement of native nox1 level could not be obtained. Therefore, we cannot completely rule out that some residual native protein might be present in antisense-treated cells and still contribute to signaling via production of ROS.

One of the consequences of Ang II–induced NAD(P)H oxidase activation is stimulation of redox-sensitive signaling kinases. As shown in Figure 6, nox1 antisense inhibited Ang II–induced activation of both Akt and p38MAPK but not ERK1/2 nor PDGF-induced phosphorylation of ERK1/2. This is consistent with observations indicating that activation of Akt and p38MAPK by Ang II but not ERK1/2 by Ang II or PDGF is partially dependent on ROS^{4 5} (and present results) and shows that antisense nox1 specifically inhibits redox-sensitive signaling. The fact that the inhibitions of Ang II–induced phosphorylation of Akt and p38MAPK with diphenylene iodonium, an inhibitor of flavin-based enzymes, were greater (up to 72%)^{4 5} than those resulting from nox1 inhibition (Figure 6, 45% and 47%, respectively) suggests that other sources of ROS exist in VSMCs. This possibility is supported by the observation that nox1 antisense increased baseline O₂^·- production (Figure 5). Although nox4 would seem to be a likely candidate based on its high expression in VSMCs (Table 1), nox4 was not upregulated in cells transduced with AdASnox1 adenovirus (B.L., K.S., D.S., K.K.G., unpublished data, 2001). This suggests either that yet another oxidase is responsible for this compensatory effect or that existing nox4 can be recruited to function in growth factor signaling when nox1 levels are reduced.

Another component of the vascular NAD(P)H oxidase is p22^phox, the smaller subunit of cytochrome b₅₅₈ present in neutrophils.²⁰ We and others have shown that p22^phox is highly expressed in VSMCs and that antisense p22^phox reduces Ang II–induced O₂^·- production and hypertrophy.^{21 23} Moreover, the coordinate upregulation of p22^phox expression and oxidase activity in Ang II–induced hypertension also supports a role for p22^phox in the VSMC oxidase.⁴² The extremely low expression of gp91^phox mRNA, along with the involvement of both nox1 (present results) and p22^phox21 in oxidase activity, suggests that nox1 (and possibly nox4) might associate with p22^phox to form a functional cytochrome in VSMCs. Definitive proof of such interaction will require additional study.

In summary, nox1 and nox4 messages are much more abundant than gp91^phox mRNA in VSMCs. Ang II markedly upregulates nox1 message in a PKC-dependent manner, whereas it downregulates nox4 mRNA. Furthermore, expression of nox1 is required for Ang II–stimulated and PDGF-stimulated O₂^·- production, and nox1 participates in Ang II–induced activation of p38MAPK and Akt, two redox-sensitive, growth-related kinases. These data support a role for nox1 in redox signaling in VSMCs and provide insight into the molecular identity of the VSMC NAD(P)H oxidase and its potentially critical role in vascular disease.

Acknowledgments

This work was supported by National Institutes of Health Grants HL38206, HL58863, and HL58000 (to K.K.G.) and CA84138 (to J.D.L.) and an American Heart Association fellowship (to D.S.). We are grateful to Dr Tong-Chuan He and Dr Bert Vogelstein from Johns Hopkins University for the gift of adenovirus construction materials and to Dr Gary H. Gibbons from Morehouse School of Medicine and Dr Brian R. Holloway from the Centers for Disease Control for allowing us to use their LightCycler instruments.

Footnotes

Original received October 16, 2000; resubmission received February 16, 2001; revised resubmission received March 19, 2001; accepted March 19, 2001.

References

1. Griendling KK, Sorescu D, Lassègue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol. 2000;20:2175–2183.

2. Patterson C, Ruef J, Madamanchi NR, Barry-Lane P, Hu Z, Horaist C, Ballinger CA, Brasier AR, Bode C, Runge MS. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin: evidence that p47^phox may participate in forming this oxidase in vitro and in vivo. J Biol Chem. 1999;274:19814–19822.

3. Sundaresan M, Zu-Xi Y, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H₂O₂ for platelet-derived growth factor signal transduction. Science. 1995;270:296–299.

4. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK. p38MAP kinase is a critical component of the redox-sensitive signaling pathways by angiotensin II: role in vascular smooth muscle cell hypertrophy. J Biol Chem. 1998;273:15022–15029.

5. Ushio-Fukai M, Alexander RW, Akers M, Yin Q, Fujio Y, Walsh K, Griendling KK. Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem. 1999;274:22699–22704.

6. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res.;2000;86:494–501.

7. Mohazzab KM, Wolin MS. Sites of superoxide anion production detected by lucigenin in calf pulmonary artery smooth muscle. Am J Physiol. 1994;267:L815–L822.

8. Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916–1923.

9. Mohazzab- H, KM, Kaminski PM, Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol. 1994;266:H2568–H2572.

10. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141–1148.

11. Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, Quinn MT. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci U S A. 1997;94:14438–14488.

12. Zafari AM, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison DG, Taylor WR, Griendling KK. Novel role of NADH/NADPH oxidase-derived hydrogen peroxide in angiotensin II–induced hypertrophy of rat vascular smooth muscle cells. Hypertension. 1998;32:488–495.

13. Babior BM. NADPH oxidase: an update. Blood. 1999;93:1464–1476.

14. Görlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R. A gp91^phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res. 2000;87:26–32.

15. Yeh LH, Park YJ, Hansalia RJ, Ahmed IS, Deshpande SS, Goldschmidt-Clermont PJ, Irani K, Alevriadou BR. Shear-induced tyrosine phosphorylation in endothelial cells requires Rac1-dependent production of ROS. Am J Physiol. 1999;276:C838–847.

16. Jones SA, O’Donnell VB, Wood JD, Broughton JP, Hughes EJ, Jones OTG. Expression of phagocyte NADPH oxidase components in human endothelial cells. Am J Physiol. 1996;271:H1626–H1634.

17. Bayraktutan U, Draper N, Lang D, Shah AM. Expression of functional neutrophil-type NADPH oxidase in cultured rat coronary microvascular endothelial cells. Cardiovasc Res. 1998;38:256–262.

18. Pagano PJ, Chanock SJ, Siwik DA, Colucci WS, Clark JK. Angiotensin II induces p67^phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. Hypertension. 1998;32:331–337.

19. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T, Goldschmidt-Clermont PJ. Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts. Science. 1997;275:1649–1652.

20. Fukui T, Lassègue B, Kai H, Alexander RW, Griendling KK. cDNA cloning and mRNA expression of cytochrome b₅₅₈ -subunit in rat vascular smooth muscle cells. Biochim Biophys Acta. 1995;1231:215–219.

21. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem. 1996;271:23317–23321.

22. Görlach A, Brandes RP, Bassus S, Kronemann N, Kirchmaier CM, Busse R, Schini-Kerth VB. Oxidative stress and expression of p22phox are involved in the up-regulation of tissue factor in vascular smooth muscle cells in response to activated platelets. FASEB J. 2000;14:1518–1528.

23. Viedt C, Soto U, Krieger-Brauer HI, Fei J, Elsing C, Kubler W, Kreuzer J. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22^phox and reactive oxygen species. Arterioscler Thromb Vasc Biol. 2000;20:940–948.

24. Suh Y, Arnold RS, Lassègue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, Lambeth JD. Cell transformation by the superoxide-generating oxidase mox1. Nature. 1999;401:79–82.

25. Lambeth JD, Cheng G, Arnold R, Edens WA. Novel homologs of gp91phox. Trends Biochem Sci. 2000;25:459–461.

26. Lassègue B, Alexander RW, Clark M, Griendling KK. Angiotensin II-induced phosphatidylcholine hydrolysis in cultured vascular smooth-muscle cells: regulation and localization. Biochem J. 1991;276:19–25.

27. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A. 1998;95:2509–2514.

28. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res. 1998;82:1298–1305.

29. Sorescu D, Somers MJ, Lassègue B, Grant S, Harrison DG, Griendling KK. Electron spin resonance characterization of the NAD(P)H oxidase in vascular smooth muscle cells. Free Radic Biol Med. 2001;30:603–612.

30. Lassègue B, Alexander RW, Nickenig G, Clark M, Murphy TJ, Griendling KK. Angiotensin II down-regulates the vascular AT₁ receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol Pharmacol. 1995;48:601–609.

31. Kai H, Fukui T, Lassègue B, Shah A, Minieri CA, Griendling KK. Prolonged exposure to agonist results in a reduction in the levels of the G_q/G₁₁ -subunits in cultured vascular smooth muscle cells. Mol Pharmacol. 1996;49:96–104.

32. Ishizaka N, Alexander RW, Laursen JB, Kai H, Fukui T, Oppermann M, Lefkowitz RJ, Lyons PR, Griendling KK. G protein-coupled receptor kinase 5 in cultured vascular smooth muscle cells and rat aorta: regulation by angiotensin II and hypertension. J Biol Chem. 1997;272:32482–32488.

33. Grant SL, Lassègue B, Griendling KK, Ushio-Fukai M, Lyons PR, Alexander RW. Specific regulation of RGS2 messenger RNA by angiotensin II in cultured vascular smooth muscle cells. Mol Pharmacol. 2000;57:460–467.

34. Griendling KK, Lassègue B, Murphy TJ, Alexander RW. Angiotensin II receptor pharmacology. Adv Pharmacol. 1994;28:269–306.

35. Benov L, Sztejnberg L, Fridovich I. Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic Biol Med. 1998;25:826–831.

36. Pagano PJ, Ito Y, Tornheim K, Gallop PM, Tauber AI, Cohen RA. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol. 1995;268:H2274–H2280.

37. Banfi B, Maturana A, Jaconi S, Arnaudeau S, Laforge T, Sinha B, Ligeti E, Demaurex N, Krause KH. A mammalian H⁺ channel generated through alternative splicing of the NADPH oxidase homolog NOH-1. Science. 2000;287:138–142.

38. Kikuchi H, Hikage M, Miyashita H, Fukumoto M. NADPH oxidase subunit, gp91^phox homologue, preferentially expressed in human colon epithelial cells. Gene. 2000;254:237–243.

39. Geiszt M, Kopp JB, Varnai P, Leto TL. Identification of Renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A. 2000;97:8010–8014.

40. De Deken X, Wang D, Many MC, Costagliola S, Libert F, Vassart G, Dumont JE, Miot F. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem. 2000;275:23227–23233.

41. Dupuy C, Ohayon R, Valent A, Noel-Hudson MS, Deme D, Virion A. Purification of a novel flavoprotein involved in the thyroid NADPH oxidase: cloning of the porcine and human cDNAs. J Biol Chem. 1999;274:37265–37269.

42. Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Q, IV, Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK. p22^phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res. 1997;80:45–51.

This article has been cited by other articles:

				S.-H. Lee, D.-W. Park, S. C. Park, Y.-K. Park, S. Y. Hong, J.-R. Kim, C.-H. Lee, and S.-H. Baek Calcium-Independent Phospholipase A2{beta}-Akt Signaling Is Involved in Lipopolysaccharide-Induced NADPH Oxidase 1 Expression and Foam Cell Formation J. Immunol., December 1, 2009; 183(11): 7497 - 7504. [Abstract] [Full Text] [PDF]

				F. D. Oakley, R. L. Smith, and J. F. Engelhardt Lipid Rafts and Caveolin-1 Coordinate Interleukin-1{beta} (IL-1{beta})-dependent Activation of NF{kappa}B by Controlling Endocytosis of Nox2 and IL-1{beta} Receptor 1 from the Plasma Membrane J. Biol. Chem., November 27, 2009; 284(48): 33255 - 33264. [Abstract] [Full Text] [PDF]

				D. J. McCrann, A. Eliades, M. Makitalo, K. Matsuno, and K. Ravid Differential expression of NADPH oxidases in megakaryocytes and their role in polyploidy Blood, August 6, 2009; 114(6): 1243 - 1249. [Abstract] [Full Text] [PDF]

				A. N. Lyle, N. N. Deshpande, Y. Taniyama, B. Seidel-Rogol, L. Pounkova, P. Du, C. Papaharalambus, B. Lassegue, and K. K. Griendling Poldip2, a Novel Regulator of Nox4 and Cytoskeletal Integrity in Vascular Smooth Muscle Cells Circ. Res., July 31, 2009; 105(3): 249 - 259. [Abstract] [Full Text] [PDF]

				G. Muteliefu, A. Enomoto, P. Jiang, M. Takahashi, and T. Niwa Indoxyl sulphate induces oxidative stress and the expression of osteoblast-specific proteins in vascular smooth muscle cells Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2051 - 2058. [Abstract] [Full Text] [PDF]

				S. J. Wilson, C. C. Cavanagh, A. M. Lesher, A. J. Frey, S. E. Russell, and E. M. Smyth Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species J. Lipid Res., June 1, 2009; 50(6): 1047 - 1056. [Abstract] [Full Text] [PDF]

				J.-S. Kim, T. Y. Huang, and G. M. Bokoch Reactive Oxygen Species Regulate a Slingshot-Cofilin Activation Pathway Mol. Biol. Cell, June 1, 2009; 20(11): 2650 - 2660. [Abstract] [Full Text] [PDF]

				A. Gabrielli, E. V. Avvedimento, and T. Krieg Scleroderma N. Engl. J. Med., May 7, 2009; 360(19): 1989 - 2003. [Full Text] [PDF]

				L. Li and B. Frei Prolonged Exposure to LPS Increases Iron, Heme, and p22phox Levels and NADPH Oxidase Activity in Human Aortic Endothelial Cells: Inhibition by Desferrioxamine Arterioscler Thromb Vasc Biol, May 1, 2009; 29(5): 732 - 738. [Abstract] [Full Text] [PDF]

				M. Y. Lee, A. S. Martin, P. K. Mehta, A. E. Dikalova, A. M. Garrido, S. R. Datla, E. Lyons, K.-H. Krause, B. Banfi, J. D. Lambeth, et al. Mechanisms of Vascular Smooth Muscle NADPH Oxidase 1 (Nox1) Contribution to Injury-Induced Neointimal Formation Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 480 - 487. [Abstract] [Full Text] [PDF]

				M. Yamaura, J. Mitsushita, S. Furuta, Y. Kiniwa, A. Ashida, Y. Goto, W. H. Shang, M. Kubodera, M. Kato, M. Takata, et al. NADPH Oxidase 4 Contributes to Transformation Phenotype of Melanoma Cells by Regulating G2-M Cell Cycle Progression Cancer Res., March 15, 2009; 69(6): 2647 - 2654. [Abstract] [Full Text] [PDF]

				W. G. Mayhan, D. M. Arrick, G. M. Sharpe, and H. Sun Nitric oxide synthase-dependent responses of the basilar artery during acute infusion of nicotine Nicotine Tob Res, March 1, 2009; 11(3): 270 - 277. [Abstract] [Full Text] [PDF]

				S. Ismail, A. Sturrock, P. Wu, B. Cahill, K. Norman, T. Huecksteadt, K. Sanders, T. Kennedy, and J. Hoidal NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: the role of autocrine production of transforming growth factor-{beta}1 and insulin-like growth factor binding protein-3 Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L489 - L499. [Abstract] [Full Text] [PDF]

				G.-X. Zhang, S. Kimura, K. Murao, J. Shimizu, H. Matsuyoshi, and M. Takaki Role of neuronal NO synthase in regulating vascular superoxide levels and mitogen-activated protein kinase phosphorylation Cardiovasc Res, February 1, 2009; 81(2): 389 - 399. [Abstract] [Full Text] [PDF]

				M. Carlstrom, E. Y. Lai, Z. Ma, A. Patzak, R. D. Brown, and A. E. G. Persson Role of NOX2 in the regulation of afferent arteriole responsiveness Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2009; 296(1): R72 - R79. [Abstract] [Full Text] [PDF]

				E. N. Lavrentyev and K. U. Malik High glucose-induced Nox1-derived superoxides downregulate PKC-{beta}II, which subsequently decreases ACE2 expression and ANG(1-7) formation in rat VSMCs Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H106 - H118. [Abstract] [Full Text] [PDF]

				H. A. Mostefai, F. Meziani, M. L. Mastronardi, A. Agouni, C. Heymes, C. Sargentini, P. Asfar, M. C. Martinez, and R. Andriantsitohaina Circulating Microparticles from Patients with Septic Shock Exert Protective Role in Vascular Function Am. J. Respir. Crit. Care Med., December 1, 2008; 178(11): 1148 - 1155. [Abstract] [Full Text] [PDF]

				J. K. Dammanahalli and Z. Sun Endothelin (ET)-1 Inhibits Nicotinamide Adenine Dinucleotide Phosphate Oxidase Activity in Human Abdominal Aortic Endothelial Cells: A Novel Function of ETB1 Receptors Endocrinology, October 1, 2008; 149(10): 4979 - 4987. [Abstract] [Full Text] [PDF]

				X. W. Cheng, T. Murohara, M. Kuzuya, H. Izawa, T. Sasaki, K. Obata, K. Nagata, T. Nishizawa, M. Kobayashi, T. Yamada, et al. Superoxide-Dependent Cathepsin Activation Is Associated with Hypertensive Myocardial Remodeling and Represents a Target for Angiotensin II Type 1 Receptor Blocker Treatment Am. J. Pathol., August 1, 2008; 173(2): 358 - 369. [Abstract] [Full Text] [PDF]

				N. Anilkumar, R. Weber, M. Zhang, A. Brewer, and A. M. Shah Nox4 and Nox2 NADPH Oxidases Mediate Distinct Cellular Redox Signaling Responses to Agonist Stimulation Arterioscler Thromb Vasc Biol, July 1, 2008; 28(7): 1347 - 1354. [Abstract] [Full Text] [PDF]

				J. V. Busik, S. Mohr, and M. B. Grant Hyperglycemia-Induced Reactive Oxygen Species Toxicity to Endothelial Cells Is Dependent on Paracrine Mediators Diabetes, July 1, 2008; 57(7): 1952 - 1965. [Abstract] [Full Text] [PDF]

				D. Gianni, B. Bohl, S. A. Courtneidge, and G. M. Bokoch The Involvement of the Tyrosine Kinase c-Src in the Regulation of Reactive Oxygen Species Generation Mediated by NADPH Oxidase-1 Mol. Biol. Cell, July 1, 2008; 19(7): 2984 - 2994. [Abstract] [Full Text] [PDF]

				W. J. Welch Angiotensin II-Dependent Superoxide: Effects on Hypertension and Vascular Dysfunction Hypertension, July 1, 2008; 52(1): 51 - 56. [Full Text] [PDF]

				M. J. Haurani, M. E. Cifuentes, A. D. Shepard, and P. J. Pagano Nox4 Oxidase Overexpression Specifically Decreases Endogenous Nox4 mRNA and Inhibits Angiotensin II-Induced Adventitial Myofibroblast Migration Hypertension, July 1, 2008; 52(1): 143 - 149. [Abstract] [Full Text] [PDF]

				A. Manea, S. A. Manea, A. V. Gafencu, M. Raicu, and M. Simionescu AP-1-Dependent Transcriptional Regulation of NADPH Oxidase in Human Aortic Smooth Muscle Cells: Role of p22phox Subunit Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 878 - 885. [Abstract] [Full Text] [PDF]

				Y. H. Looi, D. J. Grieve, A. Siva, S. J. Walker, N. Anilkumar, A. C. Cave, M. Marber, M. J. Monaghan, and A. M. Shah Involvement of Nox2 NADPH Oxidase in Adverse Cardiac Remodeling After Myocardial Infarction Hypertension, February 1, 2008; 51(2): 319 - 325. [Abstract] [Full Text] [PDF]

				H. Choi, T. L. Leto, L. Hunyady, K. J. Catt, Y. S. Bae, and S. G. Rhee Mechanism of Angiotensin II-induced Superoxide Production in Cells Reconstituted with Angiotensin Type 1 Receptor and the Components of NADPH Oxidase J. Biol. Chem., January 4, 2008; 283(1): 255 - 267. [Abstract] [Full Text] [PDF]

				R. Reed, C. Kolz, B. Potter, and P. Rocic The Mechanistic Basis for the Disparate Effects of Angiotensin II on Coronary Collateral Growth Arterioscler Thromb Vasc Biol, January 1, 2008; 28(1): 61 - 67. [Abstract] [Full Text] [PDF]

				J.-S. Kim, B. A. Diebold, B. M. Babior, U. G. Knaus, and G. M. Bokoch Regulation of Nox1 Activity via Protein Kinase A-mediated Phosphorylation of NoxA1 and 14-3-3 Binding J. Biol. Chem., November 30, 2007; 282(48): 34787 - 34800. [Abstract] [Full Text] [PDF]

				W. Ni, Y. Zhan, H. He, E. Maynard, J. A. Balschi, and P. Oettgen Ets-1 Is a Critical Transcriptional Regulator of Reactive Oxygen Species and p47phox Gene Expression in Response to Angiotensin II Circ. Res., November 9, 2007; 101(10): 985 - 994. [Abstract] [Full Text] [PDF]

				B. Wagner, J. M. Ricono, Y. Gorin, K. Block, M. Arar, D. Riley, G. G. Choudhury, and H. E. Abboud Mitogenic Signaling via Platelet-Derived Growth Factor beta in Metanephric Mesenchymal Cells J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2903 - 2911. [Abstract] [Full Text] [PDF]

				G.-X. Zhang, X.-M. Lu, S. Kimura, and A. Nishiyama Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation Cardiovasc Res, November 1, 2007; 76(2): 204 - 212. [Abstract] [Full Text] [PDF]

				E. Silva and P. Soares-da-Silva Reactive oxygen species and the regulation of renal Na+-K+-ATPase in opossum kidney cells Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1764 - R1770. [Abstract] [Full Text] [PDF]

				S. A. Cooper, A. Whaley-Connell, J. Habibi, Y. Wei, G. Lastra, C. Manrique, S. Stas, and J. R. Sowers Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2009 - H2023. [Abstract] [Full Text] [PDF]

				X. Cao, X. Dai, L. M. Parker, and D. L. Kreulen Differential Regulation of NADPH Oxidase in Sympathetic and Sensory Ganglia in Deoxycorticosterone Acetate Salt Hypertension Hypertension, October 1, 2007; 50(4): 663 - 671. [Abstract] [Full Text] [PDF]

				F. J. Miller Jr, M. Filali, G. J. Huss, B. Stanic, A. Chamseddine, T. J. Barna, and F. S. Lamb Cytokine Activation of Nuclear Factor {kappa}B in Vascular Smooth Muscle Cells Requires Signaling Endosomes Containing Nox1 and ClC-3 Circ. Res., September 28, 2007; 101(7): 663 - 671. [Abstract] [Full Text] [PDF]

				A. Sachse and G. Wolf Angiotensin II Induced Reactive Oxygen Species and the Kidney J. Am. Soc. Nephrol., September 1, 2007; 18(9): 2439 - 2446. [Abstract] [Full Text] [PDF]

				M. J. Haurani and P. J. Pagano Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: Bellwether for vascular disease? Cardiovasc Res, September 1, 2007; 75(4): 679 - 689. [Abstract] [Full Text] [PDF]

				S. Heeneman, J. C. Sluimer, and M. J.A.P. Daemen Angiotensin-Converting Enzyme and Vascular Remodeling Circ. Res., August 31, 2007; 101(5): 441 - 454. [Abstract] [Full Text] [PDF]

				P. Rocic, C. Kolz, R. Reed, B. Potter, and W. M. Chilian Optimal reactive oxygen species concentration and p38 MAP kinase are required for coronary collateral growth Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2729 - H2736. [Abstract] [Full Text] [PDF]

				S. M. Zemse, R. H. P. Hilgers, and R. C. Webb Interleukin-10 counteracts impaired endothelium-dependent relaxation induced by ANG II in murine aortic rings Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3103 - H3108. [Abstract] [Full Text] [PDF]

				B. J. Hawkins, M. Madesh, C. J. Kirkpatrick, and A. B. Fisher Superoxide Flux in Endothelial Cells via the Chloride Channel-3 Mediates Intracellular Signaling Mol. Biol. Cell, June 1, 2007; 18(6): 2002 - 2012. [Abstract] [Full Text] [PDF]

				H. Abdala-Valencia, J. Earwood, S. Bansal, M. Jansen, G. Babcock, B. Garvy, M. Wills-Karp, and J. M. Cook-Mills Nonhematopoietic NADPH oxidase regulation of lung eosinophilia and airway hyperresponsiveness in experimentally induced asthma Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1111 - L1125. [Abstract] [Full Text] [PDF]

				J. K. Bendall, R. Rinze, D. Adlam, A. L. Tatham, J. de Bono, and K. M. Channon Endothelial Nox2 Overexpression Potentiates Vascular Oxidative Stress and Hemodynamic Response to Angiotensin II: Studies in Endothelial-Targeted Nox2 Transgenic Mice Circ. Res., April 13, 2007; 100(7): 1016 - 1025. [Abstract] [Full Text] [PDF]

				I. Suzuma, T. Murakami, K. Suzuma, H. Kaneto, D. Watanabe, T. Ojima, Y. Honda, H. Takagi, and N. Yoshimura Cyclic Stretch-Induced Reactive Oxygen Species Generation Enhances Apoptosis in Retinal Pericytes Through c-Jun NH2-Terminal Kinase Activation Hypertension, February 1, 2007; 49(2): 347 - 354. [Abstract] [Full Text] [PDF]

				T. Szasz, K. Thakali, G. D. Fink, and S. W. Watts A Comparison of Arteries and Veins in Oxidative Stress: Producers, Destroyers, Function, and Disease Experimental Biology and Medicine, January 1, 2007; 232(1): 27 - 37. [Abstract] [Full Text] [PDF]

				K. Bedard and K.-H. Krause The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology Physiol Rev, January 1, 2007; 87(1): 245 - 313. [Abstract] [Full Text] [PDF]

				P. Pacher, J. S. Beckman, and L. Liaudet Nitric Oxide and Peroxynitrite in Health and Disease Physiol Rev, January 1, 2007; 87(1): 315 - 424. [Abstract] [Full Text] [PDF]

				R. E. Clempus, D. Sorescu, A. E. Dikalova, L. Pounkova, P. Jo, G. P. Sorescu, B. Lassegue, and K. K. Griendling Nox4 Is Required for Maintenance of the Differentiated Vascular Smooth Muscle Cell Phenotype Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 42 - 48. [Abstract] [Full Text] [PDF]

				P. K. Mehta and K. K. Griendling Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system Am J Physiol Cell Physiol, January 1, 2007; 292(1): C82 - C97. [Abstract] [Full Text] [PDF]

				S. B. Lee, I. H. Bae, Y. S. Bae, and H.-D. Um Link between Mitochondria and NADPH Oxidase 1 Isozyme for the Sustained Production of Reactive Oxygen Species and Cell Death J. Biol. Chem., November 24, 2006; 281(47): 36228 - 36235. [Abstract] [Full Text] [PDF]

				M. Ushio-Fukai and R. W. Alexander Caveolin-Dependent Angiotensin II Type 1 Receptor Signaling in Vascular Smooth Muscle Hypertension, November 1, 2006; 48(5): 797 - 803. [Full Text] [PDF]

				K. Ohtani, K. Egashira, Y. Ihara, K. Nakano, K. Funakoshi, G. Zhao, M. Sata, and K. Sunagawa Angiotensin II Type 1 Receptor Blockade Attenuates In-Stent Restenosis by Inhibiting Inflammation and Progenitor Cells Hypertension, October 1, 2006; 48(4): 664 - 670. [Abstract] [Full Text] [PDF]

				M. Oelze, A. Daiber, R. P. Brandes, M. Hortmann, P. Wenzel, U. Hink, E. Schulz, H. Mollnau, A. von Sandersleben, A. L. Kleschyov, et al. Nebivolol Inhibits Superoxide Formation by NADPH Oxidase and Endothelial Dysfunction in Angiotensin II-Treated Rats Hypertension, October 1, 2006; 48(4): 677 - 684. [Abstract] [Full Text] [PDF]

				S. D. Hingtgen, X. Tian, J. Yang, S. M. Dunlay, A. S. Peek, Y. Wu, R. V. Sharma, J. F. Engelhardt, and R. L. Davisson Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy Physiol Genomics, September 14, 2006; 26(3): 180 - 191. [Abstract] [Full Text] [PDF]

				M. Sarr, M. Chataigneau, S. Martins, C. Schott, J. El Bedoui, M.-H. Oak, B. Muller, T. Chataigneau, and V. B. Schini-Kerth Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: Role of NADPH oxidase Cardiovasc Res, September 1, 2006; 71(4): 794 - 802. [Abstract] [Full Text] [PDF]

				A. N. Lyle and K. K. Griendling Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology, August 1, 2006; 21: 269 - 280. [Abstract] [Full Text] [PDF]

				C. E. Murdoch, M. Zhang, A. C. Cave, and A. M. Shah NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure Cardiovasc Res, July 15, 2006; 71(2): 208 - 215. [Abstract] [Full Text] [PDF]

				R. E. Clempus and K. K. Griendling Reactive oxygen species signaling in vascular smooth muscle cells Cardiovasc Res, July 15, 2006; 71(2): 216 - 225. [Abstract] [Full Text] [PDF]

				T. M. Paravicini and R. M. Touyz Redox signaling in hypertension Cardiovasc Res, July 15, 2006; 71(2): 247 - 258. [Abstract] [Full Text] [PDF]

				H. ten Freyhaus, M. Huntgeburth, K. Wingler, J. Schnitker, A. T. Baumer, M. Vantler, M. M. Bekhite, M. Wartenberg, H. Sauer, and S. Rosenkranz Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation Cardiovasc Res, July 15, 2006; 71(2): 331 - 341. [Abstract] [Full Text] [PDF]

				H. Li, K. Witte, M. August, I. Brausch, U. Godtel-Armbrust, A. Habermeier, E. I. Closs, M. Oelze, T. Munzel, and U. Forstermann Reversal of Endothelial Nitric Oxide Synthase Uncoupling and Up-Regulation of Endothelial Nitric Oxide Synthase Expression Lowers Blood Pressure in Hypertensive Rats J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2536 - 2544. [Abstract] [Full Text] [PDF]

				V. A. Cameron, T. J. Mocatta, A. P. Pilbrow, C. M. Frampton, R. W. Troughton, A. M. Richards, and C. C. Winterbourn Angiotensin Type-1 Receptor A1166C Gene Polymorphism Correlates With Oxidative Stress Levels in Human Heart Failure Hypertension, June 1, 2006; 47(6): 1155 - 1161. [Abstract] [Full Text] [PDF]

				A. E. Vendrov, N. R. Madamanchi, Z. S. Hakim, M. Rojas, and M. S. Runge Thrombin and NAD(P)H Oxidase-Mediated Regulation of CD44 and BMP4-Id Pathway in VSMC, Restenosis, and Atherosclerosis Circ. Res., May 26, 2006; 98(10): 1254 - 1263. [Abstract] [Full Text] [PDF]

				M. Weaver, J. Liu, D. Pimentel, D. J. Reddy, P. Harding, E. L. Peterson, and P. J. Pagano Adventitial delivery of dominant-negative p67phox attenuates neointimal hyperplasia of the rat carotid artery Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1933 - H1941. [Abstract] [Full Text] [PDF]

				D. Feliers, Y. Gorin, G. Ghosh-Choudhury, H. E. Abboud, and B. S. Kasinath Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species Am J Physiol Renal Physiol, April 1, 2006; 290(4): F927 - F936. [Abstract] [Full Text] [PDF]

				J. Anrather, G. Racchumi, and C. Iadecola NF-{kappa}B Regulates Phagocytic NADPH Oxidase by Inducing the Expression of gp91phox J. Biol. Chem., March 3, 2006; 281(9): 5657 - 5667. [Abstract] [Full Text] [PDF]

				P. L. Hordijk Regulation of NADPH Oxidases: The Role of Rac Proteins Circ. Res., March 3, 2006; 98(4): 453 - 462. [Abstract] [Full Text] [PDF]

				T. Ueyama, M. Geiszt, and T. L. Leto Involvement of rac1 in activation of multicomponent nox1- and nox3-based NADPH oxidases. Mol. Cell. Biol., March 1, 2006; 26(6): 2160 - 2174. [Abstract] [Full Text] [PDF]

				N. Ardanaz and P. J. Pagano Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunction. Experimental Biology and Medicine, March 1, 2006; 231(3): 237 - 251. [Abstract] [Full Text] [PDF]

				X. Dai, X. Cao, and D. L. Kreulen Superoxide anion is elevated in sympathetic neurons in DOCA-salt hypertension via activation of NADPH oxidase Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1019 - H1026. [Abstract] [Full Text] [PDF]

				X.-Y. Yi, V. X. Li, F. Zhang, F. Yi, D. R. Matson, M. T. Jiang, and P.-L. Li Characteristics and actions of NAD(P)H oxidase on the sarcoplasmic reticulum of coronary artery smooth muscle Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1136 - H1144. [Abstract] [Full Text] [PDF]

				P. Spallarossa, P. Altieri, S. Garibaldi, G. Ghigliotti, C. Barisione, V. Manca, P. Fabbi, A. Ballestrero, C. Brunelli, and A. Barsotti Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase Cardiovasc Res, February 15, 2006; 69(3): 736 - 745. [Abstract] [Full Text] [PDF]

				Q. Fang, H. Sun, D. M. Arrick, and W. G. Mayhan Inhibition of NADPH oxidase improves impaired reactivity of pial arterioles during chronic exposure to nicotine J Appl Physiol, February 1, 2006; 100(2): 631 - 636. [Abstract] [Full Text] [PDF]

				T. J. Guzik, J. Sadowski, B. Guzik, A. Jopek, B. Kapelak, P. Przybylowski, K. Wierzbicki, R. Korbut, D. G. Harrison, and K. M. Channon Coronary Artery Superoxide Production and Nox Isoform Expression in Human Coronary Artery Disease Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 333 - 339. [Abstract] [Full Text] [PDF]

				Y. Kuwano, T. Kawahara, H. Yamamoto, S. Teshima-Kondo, K. Tominaga, K. Masuda, K. Kishi, K. Morita, and K. Rokutan Interferon-{gamma} activates transcription of NADPH oxidase 1 gene and upregulates production of superoxide anion by human large intestinal epithelial cells Am J Physiol Cell Physiol, February 1, 2006; 290(2): C433 - C443. [Abstract] [Full Text] [PDF]

				L. Xia, H. Wang, H. J. Goldberg, S. Munk, I. G. Fantus, and C. I. Whiteside Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression Am J Physiol Renal Physiol, February 1, 2006; 290(2): F345 - F356. [Abstract] [Full Text] [PDF]

				P. Modlinger, T. Chabrashvili, P. S. Gill, M. Mendonca, D. G. Harrison, K. K. Griendling, M. Li, J. Raggio, A. Wellstein, Y. Chen, et al. RNA Silencing In Vivo Reveals Role of p22phox in Rat Angiotensin Slow Pressor Response Hypertension, February 1, 2006; 47(2): 238 - 244. [Abstract] [Full Text] [PDF]

				Q. Li, M. M. Harraz, W. Zhou, L. N. Zhang, W. Ding, Y. Zhang, T. Eggleston, C. Yeaman, B. Banfi, and J. F. Engelhardt Nox2 and Rac1 Regulate H2O2-Dependent Recruitment of TRAF6 to Endosomal Interleukin-1 Receptor Complexes Mol. Cell. Biol., January 1, 2006; 26(1): 140 - 154. [Abstract] [Full Text] [PDF]

				J. Q. Liu, I. N. Zelko, E. M. Erbynn, J. S. K. Sham, and R. J. Folz Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox) Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L2 - L10. [Abstract] [Full Text] [PDF]

				A. Cave, D. Grieve, S. Johar, M. Zhang, and A. M Shah NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology Phil Trans R Soc B, December 29, 2005; 360(1464): 2327 - 2334. [Abstract] [Full Text] [PDF]

				H. Mollnau, M. Oelze, M. August, M. Wendt, A. Daiber, E. Schulz, S. Baldus, A. L. Kleschyov, A. Materne, P. Wenzel, et al. Mechanisms of Increased Vascular Superoxide Production in an Experimental Model of Idiopathic Dilated Cardiomyopathy Arterioscler Thromb Vasc Biol, December 1, 2005; 25(12): 2554 - 2559. [Abstract] [Full Text] [PDF]

				P. Rocic and P. A. Lucchesi NAD(P)H Oxidases and TGF-{beta}-Induced Cardiac Fibroblast Differentiation: Nox-4 Gets Smad Circ. Res., October 28, 2005; 97(9): 850 - 852. [Full Text] [PDF]

				J. F. Keaney Jr Oxidative Stress and the Vascular Wall: NADPH Oxidases Take Center Stage Circulation, October 25, 2005; 112(17): 2585 - 2588. [Full Text] [PDF]

				K. Matsuno, H. Yamada, K. Iwata, D. Jin, M. Katsuyama, M. Matsuki, S. Takai, K. Yamanishi, M. Miyazaki, H. Matsubara, et al. Nox1 Is Involved in Angiotensin II-Mediated Hypertension: A Study in Nox1-Deficient Mice Circulation, October 25, 2005; 112(17): 2677 - 2685. [Abstract] [Full Text] [PDF]

				A. Dikalova, R. Clempus, B. Lassegue, G. Cheng, J. McCoy, S. Dikalov, A. S. Martin, A. Lyle, D. S. Weber, D. Weiss, et al. Nox1 Overexpression Potentiates Angiotensin II-Induced Hypertension and Vascular Smooth Muscle Hypertrophy in Transgenic Mice Circulation, October 25, 2005; 112(17): 2668 - 2676. [Abstract] [Full Text] [PDF]

				C. S. Wilcox Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R913 - R935. [Abstract] [Full Text] [PDF]

				R. E. White, G. Han, C. Dimitropoulou, S. Zhu, K. Miyake, D. Fulton, S. Dave, and S. A. Barman Estrogen-induced contraction of coronary arteries is mediated by superoxide generated in vascular smooth muscle Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1468 - H1475. [Abstract] [Full Text] [PDF]

				H. Cai Hydrogen peroxide regulation of endothelial function: Origins, mechanisms, and consequences Cardiovasc Res, October 1, 2005; 68(1): 26 - 36. [Abstract] [Full Text] [PDF]

				Y. M. Kim, T. J. Guzik, Y. H. Zhang, M. H. Zhang, H. Kattach, C. Ratnatunga, R. Pillai, K. M. Channon, and B. Casadei A Myocardial Nox2 Containing NAD(P)H Oxidase Contributes to Oxidative Stress in Human Atrial Fibrillation Circ. Res., September 30, 2005; 97(7): 629 - 636. [Abstract] [Full Text] [PDF]

				L. Gao, W. Wang, Y.-L. Li, H. D. Schultz, D. Liu, K. G. Cornish, and I. H. Zucker Simvastatin Therapy Normalizes Sympathetic Neural Control in Experimental Heart Failure: Roles of Angiotensin II Type 1 Receptors and NAD(P)H Oxidase Circulation, September 20, 2005; 112(12): 1763 - 1770. [Abstract] [Full Text] [PDF]

				Y. Castier, R. P. Brandes, G. Leseche, A. Tedgui, and S. Lehoux p47phox-Dependent NADPH Oxidase Regulates Flow-Induced Vascular Remodeling Circ. Res., September 16, 2005; 97(6): 533 - 540. [Abstract] [Full Text] [PDF]

				S. Kinugawa, J. Zhang, E. Messina, E. Walsh, H. Huang, P. M. Kaminski, M. S. Wolin, and T. H. Hintze gp91phox-containing NAD(P)H oxidase mediates attenuation of nitric oxide-dependent control of myocardial oxygen consumption by ANG II Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H862 - H867. [Abstract] [Full Text] [PDF]

				G. Zalba, O. Beloqui, G. S. Jose, M. U. Moreno, A. Fortuno, and J. Diez NADPH Oxidase-Dependent Superoxide Production Is Associated With Carotid Intima-Media Thickness in Subjects Free of Clinical Atherosclerotic Disease Arterioscler Thromb Vasc Biol, July 1, 2005; 25(7): 1452 - 1457. [Abstract] [Full Text] [PDF]

				S. Wesseling, D. A. Ishola Jr., J. A. Joles, H. A. Bluyssen, H. A. Koomans, and B. Braam Resistance to oxidative stress by chronic infusion of angiotensin II in mouse kidney is not mediated by the AT2 receptor Am J Physiol Renal Physiol, June 1, 2005; 288(6): F1191 - F1200. [Abstract] [Full Text] [PDF]

				T. Ago, T. Kitazono, J. Kuroda, Y. Kumai, M. Kamouchi, H. Ooboshi, M. Wakisaka, T. Kawahara, K. Rokutan, S. Ibayashi, et al. NAD(P)H Oxidases in Rat Basilar Arterial Endothelial Cells Stroke, May 1, 2005; 36(5): 1040 - 1046. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Data Supplement All Versions of this Article: 88/9/888    most recent hh0901.090299v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lassègue, B. Articles by Griendling, K. K. Search for Related Content PubMed Articles by Lassègue, B. Articles by Griendling, K. K. Related Collections Cell signalling/signal transduction Gene regulation Growth factors/cytokines Oxidant stress